GB643853A - Medicinal capsules and process of manufacture - Google Patents
Medicinal capsules and process of manufactureInfo
- Publication number
- GB643853A GB643853A GB308/47A GB30847A GB643853A GB 643853 A GB643853 A GB 643853A GB 308/47 A GB308/47 A GB 308/47A GB 30847 A GB30847 A GB 30847A GB 643853 A GB643853 A GB 643853A
- Authority
- GB
- United Kingdom
- Prior art keywords
- cellulose
- capsules
- per cent
- glycerol
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
- A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/08—Simple coacervation, i.e. addition of highly hydrophilic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/20—Colour codes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
Abstract
A thermo-gelled film of a water-soluble methyl cellulose having a methoxyl content of 25 to 35 per cent and an intrinsic viscosity (based on a 2 per cent solution in distilled water at 20 DEG C.) of 7 to 15 centipoises, is used in the formation of a telescoping medicinal capsule. A methoxy content of 30 per cent and a viscosity of 9 centipoises is preferred. Flexibility is improved and capsules suitable for enclosing hygroscopic medicaments are made by incorporating plasticizers such as invert sugar, sorbitol, mannitol, sucrose, dextrose, monacetin, lactose, triethyl phosphate, glycerol; monoethers of glycerol such as glycerol a -methyl ethers, a - and b -glucoheptonic acid and/or their lactones and lower alkyl and glycol esters, glucono g -lactone, g -valerolactone; a -amino acids, e.g. glycine, ethyl glycinate; amines such as monoethanolamine and triethanolamine; glycols such as propylene glycol, triethylene glycol, 2-ethyl-1,3-hexanediol, 1,3-butylene glycol; glucosides such as a -methyl glucoside; acetopropanol, amides such as acetamide and propionamide. Further there may be present: (a) electrolytes, e.g. benzene sulphonic acid, toluene sulphonic acid and citric acid; (b) colouring materials such as edible dyes of animal or vegetable origin, e.g. carmine, cudbear and caramel, or synthetic dyes, e.g. amaranth, brilliant blue F.C.F., eosin, erythrosine, guinea green certified, orange I, ponceau 3R, sunset yellow F.C.F., and tartrazine; (c) substances rendering the capsules opaque, e.g. charcoal and titanium dioxide; (d) gums, e.g. acacia; (e) wetting agents, e.g. sodium dioctyl sulphosuccinate; (f) non-thermogelling cellulose derivatives, e.g. water-soluble hydroxy ethyl cellulose; (g) Carbowax-a polyethylene glycol. The capsules are formed by dipping highly-polished, stainless steel pins, maintained at, say, 65 DEG C., into a bubble-free aqueous solution of methyl cellulose of suitable viscosity, preferably maintained at 18 DEG C., and gelling should occur within 35 seconds of such contact. The temperature of the pins may be varied over, say, 40 DEG to 80 DEG C., depending upon the size of the capsules and the viscosity of the methyl cellulose employed. Before dipping, the pins are lubricated with, e.g. a mixture of equal parts of anhydrous lanolin and soft soap containing 0.1 per cent by weight of chromium trioxide. After dipping, the coated pins are rotated to facilitate even coating and dried in a kiln through which a current of air is passed, the temperature being maintained at 40 DEG C. for 30 minutes and then slowly raised to 60 DEG C. over a further 15 minutes, such drying preventing brittleness. Infra-red radiation may be used in the drying operation. The Specification as open to inspection under Sect. 91 disclosed that any water-soluble thermogelling etherified cellulose derivative may be used, e.g. ethyl substituted ethers and p methylated cellulose ethers of glycollic acid. This subject-matter does not appear in the Specification as accepted.ALSO:A telescoping medicinal capsule is formed of a thermo-gelled film of a water-soluble methyl cellulose having a methoxy content of 25 to 35 per cent and an intrinsic viscosity (2 per cent solution in distilled water at 20 DEG C) of 7 to 15 centipoises. A methoxy content of 30 per cent and viscosity of 9 centipoises is preferred. Flexibility is improved and capsules suitable for enclosing hydroscopic medicaments are made by incorporating plasticizers such as invert sugar, sorbitol, mannitol, sucrose, dextrose, lactose, monacitin, triethyl phosphate, glycerol; monoethers of glycerol such as glycerol a - methyl ether; a - and b - gluco heptonic acid and/or their lactones and lower alkyl and glycol esters, glucono d -lactone, n -valerolactone; a -amino acids, e.g. glycine, ethyl glycinate; amines such as mono- and tri-ethanolamines; glycols such as propylene glycol, triethylene glycol, 2-ethyl-1,3 hexane diol, 1,3-butylene glycol; glycosides such as a -methyl glucoside, aceto-propanol; amides such as acetamide and propionamide. The capsule wall material may also contain (a) electrolytes, e.g. benzene sulphonic acid, toluene sulphonic acid and citric acid; (b) colouring materials such as edible of animal or vegetable origin, e.g. carmine, cudbear and caramel or synthetic dyes, e.g. amaranth, brilliant blue F.C.F., losin, erythrosine, guinea green certified, orange I, porceau 3R, sunset yellow F.C.F. and tartrazine; (c) substances rendering the capsule opaque, e.g. charcoal and titanium dioxide; (d) gums, e.g. acacia; (e) wetting agents, e.g. sodium dioctyl sulphosuccinate; (f) non-thermo-gelling cellulose derivatives, e.g. water soluble hydroxyethyl cellulose; (g) carbowax-a polyethylene glycol. The capsules are formed by dipping highly polished, stainless steel pins, maintained at say 65 DEG C, into a bubble-free aqueous solution of methyl cellulose of suitable viscosity preferably maintained at 18 DEG C (see Group IVa). The Specification as open to inspection under Sect. 91 comprises capsules having as an essential ingredient any water-soluble thermo-gelling etherified cellulose derivative, e.g. ethyl substituted ethers and methylated cellulose ethers of glycollic acid. This subject-matter does not appear in the Specification as accepted.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US643853XA | 1946-04-13 | 1946-04-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB643853A true GB643853A (en) | 1950-09-27 |
Family
ID=22055582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB308/47A Expired GB643853A (en) | 1946-04-13 | 1947-01-03 | Medicinal capsules and process of manufacture |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB643853A (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1617432B1 (en) * | 1965-09-07 | 1972-05-31 | Dow Chemical Co | Process for the production of medical capsules from a solution of a cellulose ether with low viscosity |
EP0180287A2 (en) * | 1984-10-23 | 1986-05-07 | Shin-Etsu Chemical Co., Ltd. | A cellulose ether composition and a hard medicinal capsule prepared therefrom |
FR2757173A1 (en) * | 1996-12-17 | 1998-06-19 | Warner Lambert Co | POLYMERIC COMPOSITIONS OF NON-ANIMAL ORIGIN FOR FILM FORMATION |
EP1093845A2 (en) * | 1999-10-20 | 2001-04-25 | Henkel Kommanditgesellschaft auf Aktien | Microcapsules |
WO2002016020A1 (en) * | 2000-08-22 | 2002-02-28 | Henkel Kommanditgesellschaft Auf Aktien | Microcapsules |
EP1547583A2 (en) * | 2003-12-25 | 2005-06-29 | Shin-Etsu Chemical Co., Ltd. | Capsule comprising low-substituted cellulose ether |
CN100420487C (en) * | 2007-04-24 | 2008-09-24 | 辽宁大生药业有限公司 | Novel soft capsule peel composition |
WO2009006378A1 (en) * | 2007-07-05 | 2009-01-08 | Dow Global Technologies Inc. | Dissolvable film with detection functionality |
US8547524B2 (en) | 2006-03-21 | 2013-10-01 | Lau Consulting, Inc. | Active mask variable data integral imaging system and method |
WO2013164122A1 (en) * | 2012-05-02 | 2013-11-07 | Capsugel France SAS | Aqueous dispersions of controlled release polymers and shells and capsules thereof |
US10813886B2 (en) | 2013-11-04 | 2020-10-27 | Capsugel Belgium Nv | Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole |
-
1947
- 1947-01-03 GB GB308/47A patent/GB643853A/en not_active Expired
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1617432B1 (en) * | 1965-09-07 | 1972-05-31 | Dow Chemical Co | Process for the production of medical capsules from a solution of a cellulose ether with low viscosity |
EP0180287A2 (en) * | 1984-10-23 | 1986-05-07 | Shin-Etsu Chemical Co., Ltd. | A cellulose ether composition and a hard medicinal capsule prepared therefrom |
EP0180287A3 (en) * | 1984-10-23 | 1987-04-29 | Shin-Etsu Chemical Co., Ltd. | A cellulose ether composition and a hard medicinal capsule prepared therefrom |
CN1088075C (en) * | 1996-12-17 | 2002-07-24 | 沃尼尔·朗伯公司 | Polymer film composition for capsules |
WO1998027151A1 (en) * | 1996-12-17 | 1998-06-25 | Warner-Lambert Company | Polymer film compositions for capsules |
EP1057862A2 (en) * | 1996-12-17 | 2000-12-06 | Warner-Lambert Company | Polymer film compositions for capsules |
EP1057862A3 (en) * | 1996-12-17 | 2001-02-07 | Warner-Lambert Company | Polymer film compositions for capsules |
FR2757173A1 (en) * | 1996-12-17 | 1998-06-19 | Warner Lambert Co | POLYMERIC COMPOSITIONS OF NON-ANIMAL ORIGIN FOR FILM FORMATION |
EP1093845A2 (en) * | 1999-10-20 | 2001-04-25 | Henkel Kommanditgesellschaft auf Aktien | Microcapsules |
EP1093845A3 (en) * | 1999-10-20 | 2001-05-30 | Henkel Kommanditgesellschaft auf Aktien | Microcapsules |
WO2002016020A1 (en) * | 2000-08-22 | 2002-02-28 | Henkel Kommanditgesellschaft Auf Aktien | Microcapsules |
EP1547583A3 (en) * | 2003-12-25 | 2005-11-16 | Shin-Etsu Chemical Co., Ltd. | Capsule comprising low-substituted cellulose ether |
EP1547583A2 (en) * | 2003-12-25 | 2005-06-29 | Shin-Etsu Chemical Co., Ltd. | Capsule comprising low-substituted cellulose ether |
US8029821B2 (en) | 2003-12-25 | 2011-10-04 | Shin-Etsu Chemical Co. Ltd. | Capsule comprising low-substituted cellulose ether and method for preparing the same |
US8784883B2 (en) | 2003-12-25 | 2014-07-22 | Shin-Etsu Chemical Co., Ltd. | Capsule comprising low-substituted cellulose ether and method for preparing the same |
US8547524B2 (en) | 2006-03-21 | 2013-10-01 | Lau Consulting, Inc. | Active mask variable data integral imaging system and method |
CN100420487C (en) * | 2007-04-24 | 2008-09-24 | 辽宁大生药业有限公司 | Novel soft capsule peel composition |
WO2009006378A1 (en) * | 2007-07-05 | 2009-01-08 | Dow Global Technologies Inc. | Dissolvable film with detection functionality |
JP2010532421A (en) * | 2007-07-05 | 2010-10-07 | ダウ グローバル テクノロジーズ インコーポレイティド | Soluble film with detection function |
WO2013164122A1 (en) * | 2012-05-02 | 2013-11-07 | Capsugel France SAS | Aqueous dispersions of controlled release polymers and shells and capsules thereof |
EP3446713A3 (en) * | 2012-05-02 | 2019-05-15 | Capsugel Belgium NV | Aqueous dispersions of controlled release polymers and shells and capsules thereof |
US10525010B2 (en) | 2012-05-02 | 2020-01-07 | Capsugel Belgium Nv | Aqueous dispersions of controlled release polymers and shells and capsules thereof |
US10813886B2 (en) | 2013-11-04 | 2020-10-27 | Capsugel Belgium Nv | Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2526683A (en) | Methyl cellulose capsules and process of manufacture | |
GB643853A (en) | Medicinal capsules and process of manufacture | |
US4604282A (en) | Capillary cosmetic composition containing a sarsaparilla extract | |
KR100502383B1 (en) | Polymer Film Compositions for Capsules | |
SE7903817L (en) | MORANOLIN DERIVATIVES | |
ATE107855T1 (en) | MEDICINAL PRODUCT, DIETARY PRODUCT AND HYGIENIC PRODUCT IN THE FORM OF A POWDERY COMPOSITION OBTAINED BY ADSORPTION OF THE ACTIVE INGREDIENTS ON A QUICKLY SOLUBLE SUGAR AND PROCESS FOR THE MANUFACTURE OF THIS COMPOSITION. | |
CN108524374A (en) | It is a kind of for the toothpaste and its manufacturing method of a variety of oral problems and application | |
US2491475A (en) | Enteric capsule | |
GB1009957A (en) | Compositions of matter containing cariostatic agents | |
JPS59152311A (en) | Oral cavity composition | |
GB691845A (en) | Improvements in or relating to a process for the manufacture of coffee extracts in the form of soluble powder | |
SE420919B (en) | PROCEDURE FOR THE PREPARATION OF N? 722-DANSYL-L-ARGIN INGREDIENTS AND PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS THEREOF | |
GB524293A (en) | Improvements in hair dye preparations and in the manufacture thereof | |
GB1255007A (en) | Manufacturing method for ginseng cigarettes or the like | |
GB495854A (en) | Improvements in and relating to methods of treating medicaments | |
GB810537A (en) | Sweetening composition | |
GB246430A (en) | Improved manufacture of solutions of cellulose derivatives | |
SU15617A1 (en) | The method of preparation of persistent mixtures of alkali salts of nitrosamines with azo-components | |
GB293090A (en) | Process for the manufacture of elastic, easily soluble preparations of pharmaceutical products, such as sticks, balls and the like | |
ES366716A1 (en) | Procedure for obtaining new cosmetic products. (Machine-translation by Google Translate, not legally binding) | |
BG4585U1 (en) | Formulation containing water-soluble form of propolis | |
GB638630A (en) | Improvements in and relating to antisunburn preparations | |
GB659053A (en) | Process for the preparation of a transparent gel-like tooth paste, and tooth paste produced according to this process | |
ZOLLICKOFFER | ART. VIII. On the Apocunum androsxmifolium. | |
GB798074A (en) | Improvements in or relating to therapeutic compositions containing reserpine and the manufacture thereof |